Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €92.00 ($108.24) target price by research analysts at Citigroup Inc. in a research note issued to investors on Tuesday. The brokerage presently has a “buy” rating on the stock.

Several other equities analysts have also recently commented on the stock. UBS AG set a €68.00 ($80.00) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “sell” rating in a report on Wednesday, May 3rd. J P Morgan Chase & Co set a €106.40 ($125.18) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Tuesday, June 13th. Berenberg Bank set a €95.00 ($111.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Friday, June 30th. Commerzbank Ag set a €88.00 ($103.53) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Monday. Finally, Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Tuesday. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company. Fresenius Medical Care AG & Co. KGaA presently has a consensus rating of “Hold” and a consensus target price of €87.44 ($102.87).

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) opened at 78.044 on Tuesday. The stock’s 50 day moving average price is €83.68 and its 200 day moving average price is €81.11. The firm has a market cap of €23.95 billion and a PE ratio of 20.125. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €70.82 and a 12-month high of €89.07.

COPYRIGHT VIOLATION WARNING: “Citigroup Inc. Reiterates €92.00 Price Target for Fresenius Medical Care AG & Co. KGaA (FME)” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/08/citigroup-inc-reiterates-92-00-price-target-for-fresenius-medical-care-ag-co-kgaa-fme.html.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.